Nevirapine-resistant human immunodeficiency virus: Kinetics of replication and estimated prevalence in untreated patients

Journal of Virology

Volumn 70, Issue 11, 1996, Pages 7894-7899

  Havlir, Diane V ^a   Eastman, Scott ^b   Gamst, Anthony ^a   Richman, Douglas D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; NEVIRAPINE; PLACEBO; VIRUS DNA; VIRUS RNA; ZIDOVUDINE;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; LYMPHOCYTE COUNT; MATHEMATICAL MODEL; MONONUCLEAR CELL; PRIORITY JOURNAL; VIRUS MUTANT; VIRUS MUTATION; VIRUS REPLICATION;

EID: 0029798237     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.11.7894-7899.1996     Document Type: Article

References (30)

1. Cheeseman, S. H., D. V. Havlir, M. McLaughlin, T. C. Greenough, J. L. Sullivan, D. Hall, S. E. Hattox, S. A. Spector, D. S. Stein, M. Myers, and D. D. Richman. 1995. Phase I/II evaluation of nevirapinc alone and in combination with zidovudinc for infection with human immunodeficiency virus. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 8:141-151.
2. Coffin, J. M. 1995. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 267:483-489.
3. Coombs, R. W., A. C. Collier, J. P. Allain, B. Nikora, M. Leuther, G. F. Gjerset, and L. Corey. 1989. Plasma viremia in human immunodeficiency virus infection. N. Engl. J. Med. 321:1626-1631.
4. de Jong, M. D., R. Schuurman, J. M. A. Lange, and C. A. B. Boucher. 1996. Replication of a pre-existing resistant HIV-1 subpopulation in vivo after introduction of a strong selective drug pressure. Antiviral Ther. 1:33-41.
5. de Jong, M., J. Veenstra, N. Stilianakis, R. Schuuman, J. Lange, R. Boer, and C. Boucher. 1996. Host-parasite dynamics and outgrowth of virus containing a single K70R amino acid change in reverse transcriptase are respon-sible for the loss of HIV-1 RNA load suppression by zidovudine, abstr. 1. In Abstracts of the Third Conference on Retroviruses and Opportunistic Infections 1996. Infectious Diseases Society of America, Alexandria, Va.
6. Eastman, P. S., E. Boyer, L. Mole, J. Kolberg, M. Urdea, and M. Holodniy. 1995. Nonisotopic hybridization assay for determination of relative amounts of genolypic human immunodeficiency virus type 1 zidovudine resistance. J. Clin. Microbiol. 33:2777-2780.
7. Embretson, J. M., M. Zupancic, J. L. Ribas, A. Burke, P. Racz, K. Tenner-Tacz, and A. T. Haase. 1993. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature (London) 362:359-362.
8. Havlir, D. V., S. H. Cheeseman, M. McLaughlin, R. Murphy, A. Erice, S. A. Spector, T. C. Greenough, J. L. Sullivan, D. Hall, M. Myers, M. Lamson, and D. D. Richman. 1995. High dose nevirapine: safety pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection. J. Infect. Dis. 171:537-545.
9. Havlir, D. V., V. A. Johnson, D. B. Hall, P. A. Robinson, C. B. Overby. and D. D. Richman. 1995. Factors determining sustained antiviral response to nevirapine. In Abstracts of the International Workshop on Viral Resistance 1995.
10. 3. J. Infect. Dis. 172:1379-1383.
11. Ho, D. D., T. Moudgil, and M. Alam. 1989. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N. Engl. J. Med. 321:1621-1625.
12. Ho, D. D., A. U. Neumann, A. S. Perelson, W. Chen, J. M. Leonard, and M. Markowitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature (London) 373:123-126.
13. Kroodsma, K. L., M. J. Kozal, K. A. Hamed, M. A. Winters, and T. C. Merigan. 1994. Detection of drug resistance mutations in the human immunodeficiency virus type 1 (HIV-1) pol gene: differences in semen and blood HIV-1 RNA and proviral DNA. J. Infect. Dis. 170:1292-1295.
14. Lineberger, D. W., J. A. Kessler, J. A. Waterbury, V. W. Byrnes, F. Massari, S. Staszewski, and E. A. Emini. 1995. Turnover of circulating virion RNA and of cell-associated viral DNA reflects active viral replication in human immunodeficiency virus type 1-infected individuals. J. Virol. 69:2637-2639.
15. Loveday, C., S. Kay, M. Tenant-Flowers, M. Semple, U. Ayliffe, I. V. D. Weller, and R. S. Tedder. 1995. HIV-1 RNA serum-load and resistant viral genotypes during early zidovudine therapy. Lancet 345:820-824.
16. Mansky, L. M., and H. M. Temin. 1995. Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J. Virol. 69:5087-5094.
17. McCullagh, P., and J. A. Neider. 1983. Generalized linear models. Chapman & Hall, Ltd., London.
18. Najera, I., A. Holguin, M. E. Quinones-Mateu, M. A. Munoz-Fernandez, R. Najera, C. Lopez-Galindez, and E. Domingo. 1995. pol gene quasispecies of human immunodeficiency virus: mutations associated with drug resistance in virus from patients undergoing no drug therapy. J. Virol. 69:23-31.
19. Najera, I., D. D. Richman, I. Olivares, J. M. Rojas, M. A. Peinado, M. Perucho, R. Najera, and C. Lopez-Galindez. 1994. Natural occurrence of drug resistant mutations in the reverse transcriptase of human immunodeficiency virus type 1 isolates. AIDS Res. Hum. Retroviruscs 10:1479-1488.
20. Panteleo, G., C. Graziosi, J. F. Demarest, L. Butini, M. Montroni, C. H. Fox, J. M. Orenstein, D. P. Kotler, and A. S. Fauci. 1993. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature (London) 362:355-358.
21. Patterson, B. K., M. Till, P. Otto, C. Goolslby, M. R. Furtado, L. J. McBride, and S. M. Wolinsky. 1993. Detection of HIV-1 DNA and messenger RNA in individual colls by PCR-driven in situ hybridization and flow cytometry. Science 260:976-979.
22. Perelson, A. S., A. U. Neumann, M. Markowitz, J. M. Leonard, and D. D. Ho. 1996. HIV-1 dynamics in vivo: virion clearance rale, infected cell lifetime, and viral generation time. Science 271:1582-1586.
23. Richman, D. D., D. Havlir, J. Corbeil, D. Looney, C. Ignacio, S. A. Spector, J. Sullivan, S. Cheeseman, K. Barringer, D. Pauletti, C. K. Shih, M. Myers, and J. Griffin. 1994. Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy. J. Virol. 68:1660-1666.
24. Richman, D. D., C. K. Shih, I. Lowy, J. Rose, P. Prodanovich, S. Golf, and J. Griffin. 1991. Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptasc arise in tissue culture. Proc. Natl. Acad. Sci. USA 88:11241-11245.
25. Richman, D. D., V. A. Johnson, D. L. Mayers, T. Shirasaka, M. C. O'Brien, and H. Mitsuya. 1993. In vitro evaluation of experimental agents for anti-HIV activity, p. 12.9.1-12.9.21. In J. E. Coligan. A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Stober (ed.), Current protocols in immunology. John Wiley & Sons, Inc., New York.
26. Simmonds, P., L. Q. Zhang, F. McOmish, P. Balfe, C. A. Ludlam, and A. J. L. Brown. 1991. Discontinuous sequence change of human immunodeficiency virus (HIV) type 1 env sequences in plasma viral and lymphocyte-associated proviral populations in vivo: implications for models of HIV pathogenesis. J. Virol. 65:6266-6276.
27. Wei, X., S. K. Ghosh, M. E. Taylor, V. A. Johnson, E. A. Emini, P. Deutsch, J. D. Lifson, S. Bonhoeffer, M. A. Nowak, B. H. Hahn, M. S. Saag, and G. M. Shaw. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature (London) 373:117-122.
28. Winters, M. A., L. B. Tan, D. A. Katzenstein, and T. C. Merigan. 1993. Biological variation and quality control of plasma human immunodeficiency virus type 1 RNA quantitation by reverse transcriptase polymerase chain reaction. J. Clin. Microbiol. 31:2960-2966.
29. Wong, J. K., N. J. S. Fitch, F. Torriani, D. V. Havlir, and D. D. Richman. 1994. Discordance of RT sequences conferring ZDV resistance in proviral DNA form brain and spleen, abstr. 46. In Abstracts of the Third International Workshop on HIV Drug Resistance 1994.
30. Zhang, Y. M., S. C. Dawson, D. Landsman, H. C. Lane, and N. P. Salzman. 1994. Persistence of four related human immunodeficiency virus subtype during the course of zidovudine therapy: relationship between virion RNA and proviral DNA. J. Virol. 68:425-432.